| P2093 | author name string | Carla L Bregman | |
| | Anthony M Fletcher | |
| | Theodora W Salcedo | |
| | Jochen Woicke | |
| | Mark G Mense | |
| | Hengsheng Fang | |
| | Gene E Schulze | |
| | Helen E Janke | |
| | Robert H Zidell | |
| | William J Janusz | |
| P2860 | cites work | Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 | Q24290481 |
| | Cellular signaling by fibroblast growth factor receptors | Q24301087 |
| | Fibroblast growth factors | Q24542507 |
| | A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected] | Q24615444 |
| | Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells | Q24658237 |
| | Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors | Q24676378 |
| | Pegaptanib for neovascular age-related macular degeneration | Q45206481 |
| | Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. | Q45345154 |
| | Epithelial fibroblast growth factor receptor 1 regulates enamel formation. | Q46009342 |
| | Age-related changes in vascular endothelial growth factor dependency and angiopoietin-1-induced plasticity of adult blood vessels | Q46042555 |
| | The importance of signal pathway modulation in all aspects of tooth development | Q46155176 |
| | Nonclinical safety evaluation of sunitinib: a potent inhibitor of VEGF, PDGF, KIT, FLT3, and RET receptors | Q46266793 |
| | Immunolocalization of fibroblast growth factor-2 (FGF-2) in the developing root and supporting structures of the murine tooth | Q46319058 |
| | Cartilage dysplasia and tissue mineralization in the rat following administration of a FGF receptor tyrosine kinase inhibitor | Q46612804 |
| | Responsiveness of developing dental tissues to fibroblast growth factors: expression of splicing alternatives of FGFR1, -2, -3, and of FGFR4; and stimulation of cell proliferation by FGF-2, -4, -8, and -9. | Q47843780 |
| | Fgf-2 regulates enamel and dentine formation in mouse tooth germ. | Q52100625 |
| | Increased expression of fibroblast growth factor 8 in human breast cancer. | Q52179312 |
| | Expression and function of FGFs-4, -8, and -9 suggest functional redundancy and repetitive use as epithelial signals during tooth morphogenesis. | Q52189524 |
| | The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 |
| | Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation | Q27851447 |
| | Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer | Q27860681 |
| | The biology of VEGF and its receptors | Q27860704 |
| | Angiogenic growth factors in human dentine matrix | Q28139322 |
| | Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family | Q28199597 |
| | Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth | Q28240547 |
| | Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3 | Q28242697 |
| | AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer | Q28251373 |
| | R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways | Q28275289 |
| | Mutations in the gene encoding fibroblast growth factor 10 are associated with aplasia of lacrimal and salivary glands | Q28302868 |
| | Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium | Q28587604 |
| | Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice | Q28593600 |
| | FGFR activation in skeletal disorders: too much of a good thing | Q28646375 |
| | Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma | Q28678660 |
| | Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene | Q29547732 |
| | Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | Q29547733 |
| | Angiogenesis in health and disease | Q29614541 |
| | The biology of vascular endothelial growth factor | Q29615946 |
| | Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid | Q29617640 |
| | Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer | Q29622818 |
| | Expression of protein kinases C betaI, betaII, and VEGF during the differentiation of enamel epithelium in tooth development | Q31148906 |
| | Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibody | Q33657663 |
| | Molecular regulation of tooth development | Q33697485 |
| | Molecular and biological properties of vascular endothelial growth factor | Q33737216 |
| | Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins | Q33775844 |
| | Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. | Q33787009 |
| | Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice | Q33889166 |
| | Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis | Q33900066 |
| | Fibroblast growth factors and their inhibitors | Q34096067 |
| | Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate | Q34369354 |
| | Mouse models of abnormal skeletal development and homeostasis | Q34390754 |
| | Role of tyrosine kinase inhibitors in cancer therapy | Q34432091 |
| | Craniosynostosis: genes and mechanisms | Q34439564 |
| | Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis | Q34578752 |
| | Regulation of the ovarian follicular vasculature | Q34599308 |
| | Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies | Q37307140 |
| | Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. | Q37357790 |
| | Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors | Q37416895 |
| | Cellular and molecular basis of tooth eruption | Q37472189 |
| | A role for VEGF as a negative regulator of pericyte function and vessel maturation | Q39919369 |
| | Histopathological study on the PTHrP-induced incisor lesions in rats | Q40604588 |
| | Inhibition of VEGF receptors causes lung cell apoptosis and emphysema | Q40761379 |
| | FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease | Q40951616 |
| | Review article. The rat incisor in toxicologic pathology | Q41060263 |
| | Dental dysplasia in rats and mice | Q41083555 |
| | Signalling networks regulating dental development | Q41657467 |
| | VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation | Q41672985 |
| | Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration | Q41711674 |
| | Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption | Q41772601 |
| | Localization of putative stem cells in dental epithelium and their association with Notch and FGF signaling. | Q41814862 |
| | Structural features of forming and developing blood capillaries of the enamel organ of rat molar tooth germs observed by light and electron microscopy | Q42482512 |
| | Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. | Q42805124 |
| | Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants | Q43509136 |
| | Morphological classification of dental lesions induced by various antitumor drugs in mice | Q43665394 |
| | Response of the incisor tooth to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a dioxin-resistant and a dioxin-sensitive rat strain | Q44178146 |
| | Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. | Q44393459 |
| | Hexachlorobenzene-induced incisor degeneration in Sprague-Dawley rats | Q44720894 |
| | Evolution of bevacizumab-based therapy in the management of breast cancer | Q34865917 |
| | Angiogenesis in the female reproductive organs: pathological implications | Q35027037 |
| | Small-molecule inhibitors of fibroblast growth factor receptor (FGFR) tyrosine kinases (TK). | Q35061293 |
| | Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications | Q35071439 |
| | Normal and abnormal dental development | Q35095939 |
| | Regulation of vascular development by fibroblast growth factors. | Q35173667 |
| | Perspective. Osteoclastogenesis and growth plate chondrocyte differentiation: emergence of convergence | Q35617015 |
| | An integrated gene regulatory network controls stem cell proliferation in teeth | Q35829857 |
| | Evolution of the Fgf and Fgfr gene families | Q35913683 |
| | Innate immunity and angiogenesis | Q36002027 |
| | Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development | Q36064260 |
| | Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis | Q36111400 |
| | Fibroblast growth factor signaling in tumorigenesis | Q36111404 |
| | Angiogenesis: update 2005. | Q36230890 |
| | Angiogenesis in implantation | Q36268680 |
| | Recent advances in endometrial angiogenesis research | Q36279893 |
| | VEGF function in vascular pathogenesis | Q36331954 |
| | Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). | Q36346473 |
| | FGF signalling in craniofacial development and developmental disorders | Q36395698 |
| | Review of the effects of anti-angiogenic compounds on the epiphyseal growth plate | Q36421314 |
| | Biology of vascular endothelial growth factors | Q36456635 |
| | A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer | Q36509678 |
| | VEGF/VEGFR signalling as a target for inhibiting angiogenesis | Q36677407 |
| | Developmental dental toxicity of dioxin and related compounds--a review | Q36715575 |
| | Vascular endothelial growth factor (VEGF) in autoimmune diseases | Q36752775 |
| | Vascular endothelial growth factor family of ligands and receptors: review | Q36753923 |
| | Vascular endothelial growth factor: biology and therapeutic applications | Q36835234 |
| | Vasculogenesis and angiogenesis in the early human placenta | Q36851553 |
| | Spectrum of activity and mechanism of action of VEGF/PDGF inhibitors | Q36872284 |
| | Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies | Q36879368 |
| | VEGF: an essential mediator of both angiogenesis and endochondral ossification | Q36949564 |
| | The Fgf families in humans, mice, and zebrafish: their evolutional processes and roles in development, metabolism, and disease | Q36961346 |
| | The potential role of vascular endothelial growth factor (VEGF) in cartilage: how the angiogenic factor could be involved in the pathogenesis of osteoarthritis? | Q36975196 |
| | The molecular basis of class side effects due to treatment with inhibitors of the VEGF/VEGFR pathway | Q37239237 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 267-279 | |
| P577 | publication date | 2010-01-25 | |
| P1433 | published in | Toxicologic Pathology | Q7830407 |
| P1476 | title | Incisor degeneration in rats induced by vascular endothelial growth factor/fibroblast growth factor receptor tyrosine kinase inhibition | |
| P478 | volume | 38 | |